George A. Mashour, M.D., Ph.D., appointed interim executive vice dean for academic affairs/chief academic officer

He also serves the Medical School as senior associate dean for faculty and faculty development and is a professor of anesthesiology and pharmacology

Author | Kevin C. Bergquist

George A. Mashour, M.D., Ph.D.

On Dec. 5, the Board of Regents approved the appointment of George A. Mashour, M.D., Ph.D., as interim executive vice dean for academic affairs (EVDAA) in the Medical School, effective January 1, 2025. He also will serve as interim chief academic officer (CAO) for Michigan Medicine.

Mashour takes over EVDAA/CAO duties from Debra F. Weinstein, M.D., who is leaving Michigan Medicine at the end of this year to become president and chief executive officer of the Accreditation Council for Graduate Medical Education.

Mashour has served as senior associate dean for faculty and faculty development in the Medical School since May 2024. Prior to that, he chaired the Department of Anesthesiology and held the Robert B. Sweet Professorship from 2019-24. Additional leadership positions include associate dean for clinical and translational research and director of the Michigan Institute for Clinical and Health Research. In 2022, he founded the Michigan Psychedelic Center. He founded the Center for Consciousness Science in 2014.

Mashour received his medical degree and doctorate in neuroscience from Georgetown University, and studied neuroscience as a Fulbright Scholar in Berlin and Bonn. After completing residency and chief residency at Harvard Medical School and Massachusetts General Hospital, he pursued a neurosurgical anesthesiology fellowship at Michigan Medicine. In 2007, Dr. Mashour was appointed assistant professor in the departments of Anesthesiology and Neurosurgery, with an additional faculty appointment in the Neuroscience Graduate Program. He was promoted to professor in 2017 and appointed professor of pharmacology in 2021.

Mashour is an internationally recognized expert on the neurobiology of consciousness and unconsciousness. He conducts NIH-funded neuroscience research across the translational spectrum, from computational models to laboratory science to clinical trials.

He served as president of the Association of University Anesthesiologists and as a trustee of the International Anesthesia Research Society. His many awards and honors include the Excellence in Research Award from the American Society of Anesthesiologists, election as a Fellow of the American Association for the Advancement of Science, and election to the National Academy of Medicine.

In This Story

portrait of George Mashour

George A Mashour

VICE DEAN

Featured News & Stories

woman with dog smiling
Health Lab

Patient with retinitis pigmentosa receives new hope at Kellogg’s low vision clinic

Retinitis pigmentosa can lead to vision loss, but DNA testing, inherited retinal disease research and AI glasses offer new hope.
Breathe 3 Pulm Group
Department News

BREATHE-3 study offers lifeline to Michigan patients with severe emphysema

University of Michigan researchers have treated the state's first COPD patient with the investigational Apreo BREATHE Airway Scaffold as part of the BREATHE-3 study. The technology reshapes diseased airways to reduce trapped air, offering a new option for severe emphysema patients who do not qualify for traditional treatments.
family together celebrating birthday
Health Lab

Specialized care helps patient navigate rare liposarcoma diagnosis

Specialized care helps a Michigan Medicine patient navigate a rare liposarcoma diagnosis.
Department News

Medical School Honors Three Faculty Members with Endowed Professorships

The University of Michigan Medical School celebrates Dr. Salami, Dr. Kraft and Dr. Gupta on receiving endowed professorships, one of the institution’s highest faculty honors.
Department News

U-M Awards Strategic Initiative Fund Grant to Diabetes Reprogramming Initiative Led by Dr. Ganesh Palapattu

Dr. Ganesh Palapattu's Michigan Initiative to Reprogram Cells for Diabetes (MIRC-D) has been selected for funding through the University of Michigan's Strategic Initiative Fund, supporting innovative, multidisciplinary research aimed at transforming diabetes treatment.
liver with yellow circles over it
Health Lab

Evolving causes, diagnosis of drug-induced liver injury

The causes of drug-induced liver injury have evolved over the last 20 years, according to a review in Hepatology Communications.